The Associate Director, Regulatory Affairs is responsible for supporting the regulatory function and its activities, the development of regulatory strategy, and contributing the regulatory approval process (including US FDA and other regulatory authorities) for FMI products. FMI's products include diagnostic assays that provide molecular insights to physicians to guide treatment options for cancer patients. The incumbent functions as the regulatory representative on cross-functional teams and will be preparing and submitting packages to the FDA for approval of new products or new companion diagnostic indications. The incumbent will actively support the development of regulatory strategy focused on the use of NGS technology for companion diagnostic assays for cancer patients. This position partners closely with product development teams and external partners focused on development of genomic biomarkers and companion diagnostic indications.